Tag Archives: Boeing

Financial Daily Dose 11.08.2019 | Top Story: US and China Set to Roll Back Tariffs as Part of Trade Deal First Phase

BY: Michael D. Reif | November 8, 2019

The U.S. and China have tentatively [maybe?] agreed that a first phase of a trade agreement “would roll back a portion of the tariffs placed on each other’s products, a significant step toward defusing tensions between the world’s largest economies.” Though nothing’s signed at this point, the commitment-in-principle “marks the first time the United States … Continue reading

Financial Daily Dose 10.30.2019 | Top Story: Fiat Chrysler and Peugeot in Merger Talks

BY: Michael D. Reif | October 30, 2019

Fiat Chrysler and France’s Peugeot are in the midst of merger talks that, if finalized, could “create a nearly $50 billion trans-Atlantic auto giant.” One option being bandied about in the “fluid” talks is an “all-share merger of equals” – WSJ and Bloomberg and NYTimes The FOMC wraps up its October rate-setting meeting this afternoon. … Continue reading

Financial Daily Dose 10.29.2019 | Top Story: AT&T Reaches Accord with Elliott Management to End Activist Challenge

BY: Michael D. Reif | October 29, 2019

AT&T announced yesterday that it’s resolved an ongoing battle with activist Paul Singer and his Elliott Management by agreeing to keep CEO Randall Stephenson on the job through “at least 2020,” with the chair and CEO roles to be split upon his departure. AT&T also revealed that it will shed up to $10 billion of … Continue reading

Financial Daily Dose 10.24.2019 | Top Story: Lawmakers Grill Zuckerberg on Libra and Political Ads

BY: Michael D. Reif | October 24, 2019

We didn’t get flop sweat Zuck, but it was still a hot seat indeed for Facebook’s founder and CEO on the Hill yesterday, who fielded a wide range of questions from Libra to political freedom of expression on his platform – NYTimes and WSJ and Bloomberg and MarketWatch and Law360 In an effort to avoid … Continue reading

Financial Daily Dose 10.23.2019 | Top Story: Top exec exodus continues, this time at Nike, Boeing, and WeWork

BY: Michael D. Reif | October 23, 2019

Nike’s top dog, CEO Mark Parker, is stepping down at the beginning of 2020, to be replaced by board member and ServiceNow CEO John Donahoe. Parker, who will assume the role of executive chair when Donahoe takes over, has been involved in a series of controversies in recent years, including doping allegations directed at the … Continue reading

Financial Daily Dose 10.21.2019 | Top Story: Four Drug Companies Reach Last-minute Deal to Avoid Start of Federal Opioid Trial

BY: Michael D. Reif | October 21, 2019

A last-minute deal between defendants McKesson, Cardinal Health, AmerisourceBergen, and Teva and plaintiffs’ attorneys means that multidistrict opioid epidemic litigation set to kick off in Ohio federal court today will not feature them, though Walgreens could still see the courtroom today – WSJ In today’s “Don’t count your departures from coalitions of states before they … Continue reading

Financial Daily Dose 10.3.2019 | Top Story: After WTO ruling, US Hits EU with $7.5B in Tariffs Over Airbus Subsidies

BY: Michael D. Reif | October 3, 2019

We now have a price tag on the WTO-authorized sanctions that the U.S. can impose on European goods as a result of the EU’s illegal subsidies of planemaker Airbus: $7.5 billion—the “largest authorized retaliation in the WTO’s history” – NYTimes and WSJ and Bloomberg and MarketWatch and Law360 While we’re looking to the skies, upsetting … Continue reading

Financial Daily Dose 9.16.2019 | Top Story: Weekend Attack on Aramco Oil Fields Sends Energy Prices Soaring

BY: Michael D. Reif | September 16, 2019

A drone attack on Saudi Aramco oilfields this weekend affected 5% of global production and sent “energy prices substantially higher” late Sunday and early today. Analysts don’t anticipate a “severe shock to energy markets and the world economy” for the long term, but that said, the political and military fallout from the attacks threaten to … Continue reading

Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla

BY: Michael D. Reif | August 26, 2019

Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union” – WSJ Fed Chair Powell seemed to hit just about all the right notes in Jackson Hole on Friday (with … Continue reading

Financial Daily Dose 8.20.2019 | Top Story: Top Execs Signal Shift in Corporate Priorities Beyond Just Shareholder Gain

BY: Michael D. Reif | August 20, 2019

A survey of the country’s most powerful CEOs by the Business Roundtable shows an interesting shift in how they view their top priority—no longer does advancing the interests of shareholders take the top spot. Instead, the leaders identified investing in employees, delivering value to customers, and dealing “fairly and ethically with their suppliers” as primary … Continue reading